Hay-hay, Good Afternoon, This article will bring concerning hemophilia ayurvedic herbal treatment Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology see more
Stem Cell Investig. 2017; 4: 20.
Abstract
Recent advances inside induced pluripotent branch cell (iPSC) technology mark screening and discovering on beneficial agents intended the viable make better on human diseases. Human induced pluripotent branch cells (hiPSC) are the right kind on stage intended difficult potency on specific involved compounds. Ayurveda, the Indian old-fashioned arrangement on drug developed between 2,500 and 500 BC, is a science involving the intelligent formulations on herbs and minerals. It can serve while a “goldmine” intended tale neuroprotective agents worn intended centuries to behave towards neurological disorders. This revision discusses limitations inside screening drugs intended neurological disorders and the advantages offered via hiPSC integrated in the company of Indian old-fashioned arrangement on medicine. We commence via describing the course state on hiPSC technology inside research on Rett complaint (RTT) followed via the course controversies inside RTT research combined in the company of the emergence on patient-specific hiPSC that show an urgent need intended researchers to comprehend the etiology and medicine mechanism. We decide via offering recommendations to consolidate the screening on involved compounds present inside the ayurvedic medicines using the human induced pluripotent neural model arrangement intended research involving medicine finding out intended RTT. This integrative come to will fill the course understanding gap inside the old-fashioned medicines and medicine discovery.
Keywords: Human induced pluripotent branch cells (hiPSC), Rett complaint (RTT), neurodevelopmental disorder, ayurvedic medicines, medicine discovery, involved compounds, Indian Traditional Ayurvedic System
Introduction
Human induced pluripotent branch cells (hiPSC)
Induced pluripotent branch cells (iPSC) provide a large stage intended beneficial (regenerative medicine, patient specific personalized medicine, cell replacement therapy) and non-therapeutic applications (disease modeling, medicine discovery, pharmaceutical difficult and toxicology). The finding out on iPSC from mouse skin fibroblasts using retroviral mediated reactivation on four pluripotent transcription factors (OCT4, SOX2, KLF4, c-MYC) via Takahashi and Yamanaka inside 2006. Late inside 2007, Thomson and Yu (University on Wisconsin-Madison, USA) and Yamanaka et al. (University on Kyoto, Japan) converted human fibroblasts into hiPSC and revealed the employ on two alternative factors (Nanog and Lin 28) to facilitate the programming process using a lentiviral arrangement (1). The distinct properties on iPSC, self-renewal and differentiation on three germ layers similar to embryonic branch cells (ESC) are considered while tale cell sources intended studying neurodegenerative diseases (2). hiPSCs are promised to develop tale patient-specific cell therapies and research models intended inherited and acquired diseases. Neuronal model arrangement differentiation from patient-specific hiPSC to do central nervous arrangement (3) is a high-throughput screening stage intended tale beneficial targets and drugs.
An terminal neurological disorder—Rett complaint (RTT)
RTT (OMIN # 312750), a rare and terminal postnatal neurological illness mainly affecting females in the company of an incidence on 1 inside 10,000 (4) is characterized via an apparently non- representative stage intended the first 6–18 months on age followed via apraxia, deceleration on head growth, gait abnormalities, stereotypic hand movements, and mental retardation. Classical RTT caused via MeCP2 mutations occur mainly while C > T transitions on CpG dinucleotides mostly on the concerned X chromosome (5). There are extra than 300 dissimilar mutations establish inside the MeCP2 gene inside which 90% were traditional patients. Most on these mutations are establish inside eight dissimilar “hot spots” such while missense or nonsense mutations within the MBD (R106W, R133C, T158M, and R168X) or TRD (R255X, R270X, R294X, and R306C) (6). Small C-terminal deletions, in the company of single or both breakpoints located within the “deleted prone region” (DPR) on exon 4, account intended 10% on the cases. Atypical RTT caused via mutations inside either cyclin-dependent kinase-like 5 (CDKL5) and netrinG1 (NTNG1) or FOXG1/XBF-1 (7-9). However, at meanest 5% on standard forms and extra other unusual forms are not linked to a scrap of on 4 genes famous to be present involved inside the disease. Sudden unexpected death occurs inside one-quarter on deaths caused via RTT (10). The course and severity on RTT are determined via the location, type, severity on mutation and X-inactivation. Therefore, two girls on the same age in the company of the same mutation can appear rather different. We already detailed about the fundamental understanding on RTT, MeCP2, and hiPSCs inside our earlier publication (11).
RTT & hiPSC research inside India
RTT, the second most common origin on intellectual disability inside girls following Down complaint inside girls and women, was first recognized inside the 1960s and the first communicate from India was inside 1994 (12). Though RTT has a prevalence on 1 per 10,000 to 22,000 (13) inside India, there are very few studies and case reports on RTT inside India (14). Some on the studies were detection on two deletions on 44 bp (c.1157_1200del44 or p.L386fs) and 38 bp (c.1151_1188del38 or p.P384fs) inside exon 4 or C-terminal segment (CTS) area on MeCP2 inside traditional RTT patients on Indian beginning (15); an distinct family carrying non-identical MeCP2 mutations inside exon 2 wherein the proband in the company of traditional RTT was carrying a de-novo early truncating frameshift mutation while her asymptomatic female parent was carrying a missense mutation were both predicted while pathogenic mutations (16); c.1160C > T (P387L) inside exon 4 on the MeCP2 gene homozygous mutation inside Indian woman patient was too reported recently (17). RTT is now recognized while single on the non-curable devastating neurodevelopmental disorders (18) that greatly involve society (19). Approximately, about 50 revision articles were published about iPSC inside India and a lesser number on research be employed done inside hiPSC especially about characterization, differentiation and reprogramming factors.
There is a holistic remedy intended curing the postnatal neurological disorders using the ancient medicinal systems like Siddha and Ayurveda inside India. We more distant referred many just gone in-depth reviews on hiPSC and the curative ayurvedic drugs intended neurodegenerative disorders mainly intended RTT.
Therapeutic mark intended treating RTT
The MeCP2 gene is important intended well cerebrum activity. Mutations inside MeCP2 gene alter the position on MeCP2 and some downstream factors, which can origin neuronal defects inside RTT.
MeCP2-Glutamatergic neurons
There are two types on neurons play a key part inside RTT such while inhibitory and excitatory neurons. RTT affects every part on the brain. Generally, excitatory neurons are thought to carry information run while inhibitory neurons are required intended tuning the circuits. Restoring MeCP2 gene declaration only inside glutamatergic neurons leads to complementary phenotypes on tremor, anxiety, and acoustic startle response (20).
MeCP2-GABAergic neurons
The inhibitory GABAergic neurons results inside communal problems and boring behaviors. Genetically restoring MeCP2 declaration only inside GABAergic neurons on male MeCP2 null mice enhanced inhibitory signaling, long lifespan, rescued ataxia, apraxia, and communal abnormalities yet did not get out shake or anxiety. Restoring MeCP2 inside neither excitatory nor inhibitory neurons alone is adequate to fully get out untimely lethality, RTT-like symptoms, and RTT. Hence, modulating the excitatory/inhibitory balance via GABAergic neurons could prove a practical beneficial alternative inside RTT (21).
MeCP2 inside cholinergic neurons
MeCP2 inside cholinergic neurons is necessary and adequate intended autonomic cardiac control, thermoregulation, and survival. Targeting the overactive parasympathetic arrangement may be present a useful beneficial strategy to prevent rapid unexpected death inside RTT (10).
Downstream gene target
Loss on MeCP2 function inside RTT elevates PTP1B levels and thereby impairs insulin signaling and glucose metabolism. PTPN1 encodes PTP1B which is a vital metabolic regulator that inhibits insulin signaling via directly dephosphorylating the insulin receptor and IRS1. Therefore, inhibition on PTP1B is a direct mark on MeCP2. Animal cram via Krishnan et al. 2015 (22) revealed that the small- molecule inhibitors on PTP1B, the difluoromethyl phosphonic sour CPT157633 and the ursolic sour derivative UA0713 act while a possible downstream gene mark intended RTT (23).
MeCP2 reexpression
RTT shows a significant shortfall inside neuron-specific K+-Cl- cotransporter 2 (KCC2) expression, resulting inside a delayed GABA practical switch from excitation to inhibition. Restoring KCC2 position rescues GABA practical deficits and so acts while a downstream gene mark to behave towards RTT (18).
NF-κB pathway
Loss on MeCP2 function leads to upregulation on Irak1 gene, which is downstream on MeCP2 resulting unusual start on NF-κB signaling. Macklis et al. inside 2016 establish the decrease on NF-κB signaling via genes can increase the dendritic complexity on cortical callosal forecast neurons (CPN) and extends lifespan inside RTT, indicating possible beneficial strategies on RTT pathogenesis (24).
Clinical trials and medicine finding out inside RTT
Current beneficial approaches aim to increase the declaration on brain-derived neurotrophic element (BDNF), a neurotrophin involved inside cerebrum growth and plasticity to counteract the lack inside MeCP2. BDNF does not cross the lifeblood cerebrum barrier (BBB), and so it has not at all immediate beneficial application intended RTT patients; however an alternative growth factor, insulin-like growth element 1 (IGF1), crosses the BBB and shares similar properties and functions in the company of BDNF. Animal research reveals that systemic administration on the involved peptide on IGF1 improves physiological behavior and existence inside MeCP2 mutant mice suggesting that IGF1 can be present a treatment inside RTT patients (25). IGF1 can too get out the impaired KCC2 position while a downstream gene mark inside RTT. Phase I cold trials on recombinant IGF-1 treatment inside patients in the company of RTT keep produced encouraging outcomes leads to continuing Phase II trials. There are about 40 studies on RTT present inside the clinicaltrial.gov, the medicine based studies were listed inside the beneath Table 1. There is not at all medicine marketed intended treating RTT till now.
Table 1
List on cold trials inside Rett syndrome
| Clinical case ID | Trial title | Drug tested | Route | Phase | Status | Sponsor | Location |
|---|---|---|---|---|---|---|---|
| NCT02023424 (SHEBA-12-9855-BBZ-CTIL) | An open label, investigative cram to investigate the treatment consequence on glatiramer acetate (Copaxone) on girls in the company of Rett syndrome | Glatiramer acetate (Copaxone) | Sub cutaneous injection | I | Unknown | Sheba Medical Center | Israel |
| NCT02562820 | Ketamine intended the treatment on Rett syndrome: an investigative trial | Ketamine | Intravenous infusion | I | Ongoing, yet not recruiting participants | The Cleveland Clinic | United States |
| NCT02061137 | A stage 1 cold cram to determine security and efficacy on vocal fingolimod (FTY720) inside children in the company of Rett syndrome | Fingolimod (FTY720); other name: Gilenya | Oral | I/II | Ongoing, yet not recruiting participants | University Hospital, Basel, Switzerland; Novartis | Switzerland |
| NCT01253317 | Pharmacological treatment on Rett complaint via stimulation on synaptic maturation in the company of IGF-1 | rhIGF-1 | Subcutaneous injection | I/II | Completed | Walter Kaufmann; International Rett Syndrome Foundation; Autism Speaks | United States |
| NCT00990691, 2007-006739-30, 2007-37 | Pilot cram on the effects on the desipramine on the neurovegetative parameters on the youngster in the company of Rett syndrome | Desipramine | Oral | II | Completed | Assistance Publique Hopitaux De Marseille | France |
| NCT02153723; Rett complaint Copaxone | Pharmacological treatment on Rett complaint in the company of glatiramer acetate (Copaxone) | Glatiramer acetate/Copaxone | Subcutaneous injection | II | Ongoing, yet not recruiting participants | Montefiore Medical Center Rett Syndrome Research Trust | United States |
| NCT01777542, IRB-P00005610 | Pharmacological treatment on Rett complaint via stimulation on synaptic maturation in the company of recombinant human IGF-1 [Mecasermin (rDNA) injection] | Recombinant human insulin growth element 1 (rhIGF-1); other names: Mecasermin (rDNA); Increlex | Subcutaneous injection | II | Completed | Boston Children’s Hospital; International Rett Syndrome Foundation | United States |
| NCT01703533, Neu-2566-RETT-001 | A stage II randomized, double-blind, placebo-controlled, parallel-group, dose-escalation cram on NNZ-2566 inside Rett syndrome | Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566); other name: Trofinetide | Injection | II | Completed | Neuren Pharmaceuticals Limited; Baylor College on Medicine; Texas Children’s Hospital; International Rett Syndrome Foundation | United States |
| NCT02715115 | A randomized double-blind, placebo-controlled, dose- ranging cram on the security and pharmacokinetics on vocal NNZ-2566 inside pediatric Rett syndrome | Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566); other name: Trofinetide | Injection | II | Ongoing, yet not recruiting participants | Neuren Pharmaceuticals Limited rettsyndrome.org | United States |
| NCT02563860 | Pharmacological treatment on Rett complaint in the company of 3-Hydroxy-3 Methylglutaryl-coenzyme A reductase inhibitor-lovastatin (Mevacor) | Lovastatin; other name: Mevacor | - | II | Completed | Montefiore Medical Center; Rett Syndrome Research Trust | United States |
| NCT00593957; FD2408, FD-004247-01 | Trial on Dextromethorphan inside Rett Syndrome | Dextrometh orphan; other name: Delsym | Oral syrup | II | Terminated | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | United States |
| NCT01520363 FD-004247-01 | Placebo-controlled case on dextromethorphan inside Rett syndrome | Dextrometh orphan | Oral | II | Open | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | United States |
| NCT01822249, OPBGC&RS_12_ 003, 2012-005021-76 | A stage 2A randomized, placebo-controlled case on EPI-743 inside children in the company of Rett syndrome | EPI-743 | Oral | II | Completed | Edison Pharmaceuticals Inc. | Italy |
| 2008-000787-16, C07-22 | Open-label cram on the consequence on fluoxetine inside patients aged 8-28 years in the company of Rett complaint typical | Fluoxetine; trade name: Prozac | Oral | II | Ongoing | Inserm | France |
| NCT02696044 | Treatment on mitochondrial dysfunction inside Rett complaint in the company of Triheptanoin: an open- label, 10-subject cold case on UX007 (Triheptanoin) inside the treatment on mitochondrial dysfunction inside participants in the company of Rett syndrome, dyskinesia, and epilepsy | (UX007) Triheptanoin | Oral | II | Open | Emory University; Ultragenyx Pharmaceutical Inc. | United States |
| NCT02790034 | A randomized, double-blind, placebo-controlled 6-month cram to evaluate the efficacy, safety, and tolerability on sarizotan inside patients in the company of Rett complaint in the company of respiratory symptoms | Sarizotan; Other Names: sarizotan hydrochloride; EMD128130 | Oral (Capsule) | II/III | Open | Newron | United States, India, Italy |
| NCT00069550, HD024448 5P01 HD024448 | Pathogenesis on Rett syndrome: normal history and treatment | Dextrometh orphan drug: donepezil hydrochloride | – | III | Unknown | Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD) | United States |
Current trends inside hiPSC technology
Recent advances inside branch cell research, especially inside the growth on iPSC technology, provide a new model intended medicine screening via permitting the employ on human cells in the company of the same genetic makeup while the patients without the standard quantity constraints associated in the company of patient primary cells (26). The delivery on iPS cells treated in the company of mitomycin C (MMC) loading in the company of gold nanorods (AuNRs) intended the targeted photothermal treatment on gastric tumour resulted inside killing the tumor cells via the heat generated from the gold nanorods. This suggested that pre-treated iPS cells in the company of MMC can be present worn while a tale and secure come to intended targeted tumor remedy (27). Nanoplatform via the combination on Au nanorods, SiO2, CXCR4 nanoparticles in the company of hiPSC intended the photothermal treatment paves a large promise intended cold translation inside the alongside time to come (28). hiPSCs can be present worn while an autologous source intended cell therapy. Transplantation on human iPSC-derived cells is a secure and successful come to to promoting improvement following stroke and can be present worn to supply the injured cerebrum in the company of new neurons intended replacement (29). Furthermore, the power to act body part systems in the company of hiPSCs may approve intended studying the effects on a drug’s metabolites on mark and non-target cell types. This is an important part on a drug’s border consequence outline that can currently be present observed only inside animal models or cold trials. hiPSCs plays a larger part inside studying the effects on polypharmacy, both inside the general population and specific patient. Recently, “tissue chip” devices keep become prominent as these cellular models are designed to recapitulate the structure and function on human organs, such while the lung, liver and heart; therefore, they are often called “organs-on-a-chip” or “human-on-a-chip” (30). Three-dimensional model systems are expected to be present able to do human physiology extra accurately than old-fashioned two-dimensional cultures, in the midst of which “organ-on-a-chip” and “body-on-a-chip” are advanced formats on “tissue-on-a-chip” devices (31). Once “tissue-on-a-chip” devices are developed and received while a standard part on the preclinical medicine growth process, they can be present worn to predict whether a medicine competitor is secure or toxic to humans inside the security on the laboratory setting (32). This is an increasingly important point on medicine development, taking into account the commonality on many medication regimens and a patient population that will disposed increase the number on medications while they age (33). A total on 1,500 compounds were tested on wild-type hiPSC-derived neural parent cells intended their consequence on the Wnt/β-catenin signaling pathway intended identifying a possible tale neuropsychiatric medicine (34).
Limitations associated in the company of medicine screening intended RTT
Drug screening intended neurological disorders is a tedious process and it is unimportant to confirm the efficacy on the respective medicine dosage. The main topic is the difference between the mice and human neurons action beside the drug. Drug treatment using hiPSC derived neuron model arrangement is extra successful intended neurodevelopmental disorders than late-onset neurodegenerative disorders, disposed as on the foetal-like properties on the cells (35). It is difficult to correlate the medicine pharmacodynamics inside the neurodegenerative illness animal models. There are too some limitations associated in the company of medicine screening regular inside hiPSC such while genetic aberration and teratoma formation via retroviral or lentiviral systems on gene incorporation inside the generation on iPSCs. Five oncogenes were establish to overexpress inside iPSCs whereas the oncogene RAB25 was establish to express inside cells derived from iPSCs (36). Apart from these limitations, generation on patient specific or mutation specific hiPSC model arrangement is a large challenge and cost effective yet ultimately it can be present the immortal modal arrangement while compared in the company of animal models. It is unlikely that hiPSC technology will well model intended the whole amount disorders (37).
Indian old-fashioned ayurvedic system: curative drugs intended neurological disorders
Ayurveda is a science on life and science on longevity to condition and personalized medicine. India is famous intended its old-fashioned medicinal systems—Ayurveda, Siddha, and Unani. Ayurveda has an extensive pharmacopeia, mainly herbs and minerals. The Ayurvedic concept appeared and developed between 2,500 and 500 BC inside India, which is the largest promoter on medicinal plants. There are currently about 20,000 medicinal plants keep been recorded. Clinical trials are continuing inside extra than 100 normal product derived drugs and at meanest 100 molecules/compounds are inside the preclinical growth stage (38). In the Indian arrangement on medicine, the following medicinal plants keep shown promising action inside neuropsychopharmacology: Allium sativum, Bacopamonnierae, Centellaasiatica, Celastruspaniculatus, Nicotianatabaccum, Withaniasomnifera, Ricinuscommunis, Salvia officinalis, Ginkgo biloba, Huperizaserrata, Angelica sinensis, Uncariatomentosa, Hypericumperforatum, Physostigmavenosum, Acorus Calamus, Curcuma longa, Terminaliachebula, Crocus sativus, Enhydrafluctuans, Valerianawallichii, Glycyrrhizaglabra etc. (39). The Medhya Rasayanas are group on medicinal plants described inside Ayurveda, famous to better mental health, intelligence ability, amnesty and hence longevity. Medha way intellect/retention and Rasayana way beneficial procedure. Medhya Rasayana is a group on 4 medicinal plants that can be present worn singly or inside combinations.
Mandukaparni (Centella asiatica). Useful inside treating mental retardation (improvement inside performance IQ), Social Quotient, immediate mind span.
Yashtimadhu (Glycyrrhiza glabra). Spatial learning, first for free radical scavenging, cerebral ischemia and antioxidant capacity to LDL oxidation. It increases the distribution into the CNS system, improves learning and mind on scopolamine-induced dementia.
Guduchi (Tinospora cordifolia). Strong for free radical scavenging properties beside reactive oxygen and nitrogen species. It is useful intended treatment on improving behavior disorders, mental shortfall and IQ levels.
Shankhpushpi (Convolvulus pluricaulis). Anxiolytic and mind enhancing, mood elevating, retard cerebrum aging (40).
Phytochemical based antioxidants may keep neuroprotective (preventing apoptosis) and neuroregenerative roles, via reducing or reversing cellular damage and via slowing progression on neuronal cell loss. There is ample technological and empirical evidence supporting the employ on antioxidants intended the government on neurological disorders. As the focus on drug shifts from the treatment on manifest disease to prevention, herbal drug is coming into consideration, individual a renaissance on age-old human tradition (41).
Projected curative drugs intended RTT: Ayurveda in the company of hiPSC technology
Medhya Rasayana will make better the symptoms on RTT. The treatment is cost effective and devoid on border effects. As so far the drugs tested intended RTT using hiPSC neuronal modal arrangement were having action on synapse number, vertebrae number and soma size. The part on ‘Medhya drugs’ inside neuronal branch cells differentiation is too described before (42). Earlier reports show that ‘Rasayan drugs’ could be present worn inside branch cell remedy based on the regeneration and cell renewal properties. A tablet prepared from four Medhya Rasayana herbs aid inside yielding rich medicament in the company of the same efficacy while per the classically proposed medicine dosage at lower dose (43). The involved compounds inside Medhya drugs will reverse neurological disorders and psychomotor activities (40). Hence, these involved compounds pave a way to make better the RTT symptoms like boring hand movements and mental impairment. Figure 1 depicts the drugs tested and projected Madhya drugs need to test inside the hiPSC-RTT neuronal model system.
Way forward and conclusions
Comprehensive research on the finding out on tale neuroprotective medicine candidates has proven that normal products, such while plant extracts and their bioactive compounds, can keep tremendous possible while lead neuroprotective candidates. A source on herb-based drugs severely compromises real perception on Ayurveda, which insists on restoring balance to doshas and dhatus, and preventing a recurrence on their vitiation, while the first priority. Identification and characterization on new medicinal plants to make better neurological diseases and cerebrum injuries are the vital and increasing technological interest inside just gone years. There are extra than 120 old-fashioned medicines that are individual worn intended the remedy on central nervous arrangement (CNS) disorders inside Asian countries (49). Solely using herbal drugs is beside the ethos on Ayurveda. Sadly, regular inside India, course research and practice on Ayurveda are moving on the lines on allopathy where drugs take center stage. Unfortunately, modern drug based psychoactive drugs keep met in the company of limited success inside the treatment on various neurological and psychiatric disorders due to multi-factorial nature on these diseases. The world is hard to move to holistic and integrative approaches, which represent the core on Ayurveda. Using hiPSCs inside stage I cold trials may provide a extra sensitive assay intended a competitor drug’s toxicity and security compared in the company of conventional cold case phases. Hence, inside time to come the integrative come to on tale medicine finding out from Ayurveda using hiPSC will pave the signal intended drugging the undruggable diseases.
Acknowledgements
The composer would like to thank the Human Genetics Laboratory, Bharathiar University, India intended if necessary infrastructure facilities to carry out this article.
Footnotes
Conflicts on Interest: The authors keep not at all conflicts on interest to declare.
References
1. Chou BK, Gu H, Gao Y, et al. A facile method to found human induced pluripotent branch cells from adult lifeblood cells under feeder-free and xeno-free culture conditions: a clinically obedient approach. Stem Cells Transl Med 2015;4:320-32. 10.5966/sctm.2014-0214 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
2. Li W, Chen S, Li JY. Human induced pluripotent branch cells inside Parkinson's disease: A tale cell source on cell remedy and disease modeling. Prog Neurobiol 2015;134:161-77. 10.1016/j.pneurobio.2015.09.009 [PubMed] [CrossRef] [Google Scholar]
3. Marchetto MC, Carromeu C, Acab A, et al. A model intended neural growth and treatment on Rett complaint using human induced pluripotent branch cells. Cell 2010;143:527-39. 10.1016/j.cell.2010.10.016 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
4. Dunn HG, MacLeod PM. Rett syndrome: revision on biological abnormalities. Can J Neurol Sci 2001;28:16-29. [PubMed] [Google Scholar]
5. Trappe R, Laccone F, Cobilanschi J, et al. MECP2 mutations inside intermittent cases on Rett complaint are nearly solely on concerned origin. Am J Hum Genet 2001;68:1093-101. 10.1086/320109 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
6. Schanen C, Houwink EJ, Dorrani N, et al. Phenotypic manifestations on MECP2 mutations inside traditional and unusual Rett syndrome. Am J Med Genet A 2004;126A:129-40. 10.1002/ajmg.a.20571 [PubMed] [CrossRef] [Google Scholar]
7. Patriarchi T, Amabile S, Frullanti E, et al. Imbalance on excitatory/inhibitory synaptic protein declaration inside iPSC-derived neurons from FOXG1(+/-) patients and inside foxg1(+/-) mice. Eur J Hum Genet 2016;24:871-80. 10.1038/ejhg.2015.216 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
8. Das DK, Jadhav V, Ghattargi VC, et al. Novel mutation inside forkhead box G1 (FOXG1) gene inside an Indian patient in the company of Rett syndrome. Gene 2014;538:109-12. 10.1016/j.gene.2013.12.063 [PubMed] [CrossRef] [Google Scholar]
9. Ricciardi S, Ungaro F, Hambrock M, et al. CDKL5 ensures excitatory synapse stability via reinforcing NGL-1-PSD95 interaction inside the postsynaptic carriage and is impaired inside patient iPSC-derived neurons. Nat Cell Biol 2012;14:911-23. 10.1038/ncb2566 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
10. Herrera JA, Ward CS, Wehrens XH, et al. Methyl-CpG binding-protein 2 function inside cholinergic neurons mediates cardiac arrhythmogenesis. Hum Mol Genet 2016;25:4983-95. [PMC for free article] [PubMed] [Google Scholar]
11. Balachandar V, Dhivya V, Gomathi M, et al. A revision on Rett complaint (RTT) in the company of induced pluripotent branch cells. Stem Cell Investig 2016;3:52. 10.21037/sci.2016.09.05 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
12. Kalra V, Sud DT. Rett syndrome. Indian Pediatr 1994;31:711-5. [PubMed] [Google Scholar]
13. Jellinger KA. Rett Syndrome -- an update. J Neural Transm (Vienna) 2003;110:681-701. 10.1007/s00702-003-0822-z [PubMed] [CrossRef] [Google Scholar]
14. Kumar S, Alexander M, Gnanamuthu C. Recent knowledge in the company of Rett complaint at a tertiary be concerned center. Neurol India 2004;52:494-5. [PubMed] [Google Scholar]
15. Khajuria R, Sapra S, Ghosh M, et al. Novel human obsessive mutations. Gene symbol: MECP2. Disease: Rett Syndrome. Hum Genet 2010;127:117-8. [PubMed] [Google Scholar]
16. Khajuria R, Gupta N, Sapra S, et al. A tale MECP2 change inside an indian boy in the company of variant rett phenotype and congenital blindness: implications intended genetic counseling and prenatal diagnosis. J Child Neurol 2011;26:209-13. 10.1177/0883073810378535 [PubMed] [CrossRef] [Google Scholar]
17. Bhanushali AA, Mandsaurwala A, Das BR. Homozygous c.1160C>T (P38L) inside the MECP2 gene inside a woman Rett complaint patient. J Clin Neurosci 2016;25:127-9. 10.1016/j.jocn.2015.08.040 [PubMed] [CrossRef] [Google Scholar]
18. Tang X, Kim J, Zhou L, et al. KCC2 rescues practical deficits inside human neurons derived from patients in the company of Rett syndrome. Proc Natl Acad Sci U S A 2016;113:751-6. 10.1073/pnas.1524013113 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
19. Jung YW, Hysolli E, Kim KY, et al. Human induced pluripotent branch cells and neurodegenerative disease: prospects intended tale therapies. Curr Opin Neurol 2012;25:125-30. 10.1097/WCO.0b013e3283518226 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
20. Meng X, Wang W, Lu H, et al. Manipulations on MeCP2 inside glutamatergic neurons highlight their contributions to Rett and other neurological disorders. Elife 2016;5:e14199. 10.7554/eLife.14199 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
21. Ure K, Lu H, Wang W, et al. Restoration on Mecp2 declaration inside GABAergic neurons is adequate to get out many disease features inside a mouse model on Rett syndrome. Elife 2016;5:e14198. 10.7554/eLife.14198 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
22. Krishnan N, Krishnan K, Connors CR, et al. PTP1B inhibition suggests a beneficial strategy intended Rett syndrome. J Clin Invest 2015;125:3163-77. 10.1172/JCI80323 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
24. Kishi N, MacDonald JL, Ye J, et al. Reduction on aberrant NF-κB signalling ameliorates Rett complaint phenotypes inside Mecp2-null mice. Nat Commun 2016;7:10520. 10.1038/ncomms10520 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
25. Pini G, Scusa MF, Congiu L, et al. IGF1 while a Potential Treatment intended Rett Syndrome: Safety Assessment inside Six Rett Patients. Autism Res Treat 2012;2012:679801. 10.1155/2012/679801 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
26. Xu XH, Zhong Z. Disease modeling and medicine screening intended neurological diseases using human induced pluripotent branch cells. Acta Pharmacol Sin 2013;34:755-64. 10.1038/aps.2013.63 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
27. Yang M, Liu Y, Hou W, et al. Mitomycin C-treated human-induced pluripotent branch cells while a secure delivery arrangement on gold nanorods intended targeted photothermal remedy on gastric cancer. Nanoscale 2017;9:334-340. 10.1039/C6NR06851K [PubMed] [CrossRef] [Google Scholar]
28. Liu Y, Yang M, Zhang J, et al. Human Induced Pluripotent Stem Cells intended Tumor Targeted Delivery on Gold Nanorods and Enhanced Photothermal Therapy. ACS Nano 2016;10:2375-85. 10.1021/acsnano.5b07172 [PubMed] [CrossRef] [Google Scholar]
29. Oki K, Tatarishvili J, Wood J, et al. Human-induced pluripotent branch cells form practical neurons and better improvement following grafting inside stroke-damaged brain. Stem Cells 2012;30:1120-33. 10.1002/stem.1104 [PubMed] [CrossRef] [Google Scholar]
30. Luni C, Serena E, Elvassore N. Human-on-chip intended remedy growth and central science. Curr Opin Biotechnol 2014;25:45-50. 10.1016/j.copbio.2013.08.015 [PubMed] [CrossRef] [Google Scholar]
31. Skardal A, Shupe T, Atala A. Organoid-on-a-chip and body-on-a-chip systems intended medicine screening and disease modeling. Drug Discov Today 2016;21:1399-411. 10.1016/j.drudis.2016.07.003 [PubMed] [CrossRef] [Google Scholar]
32. Hosoya M, Czysz K. Translational Prospects and Challenges inside Human Induced Pluripotent Stem Cell Research inside Drug Discovery. Cells 2016;5:E46. 10.3390/cells5040046 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
33. Ko HC, Gelb BD. Concise review: medicine finding out inside the age on the induced pluripotent branch cell. Stem Cells Transl Med 2014;3:500-9. 10.5966/sctm.2013-0162 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
34. Zhao WN, Cheng C, Theriault KM, et al. A high-throughput guard intended Wnt/β-catenin signaling pathway modulators inside human iPSC-derived neural progenitors. J Biomol Screen 2012;17:1252-63. 10.1177/1087057112456876 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
35. Rajamohan D, Matsa E, Kalra S, et al. Current position on medicine screening and disease modelling inside human pluripotent branch cells. Bioessays 2013;35:281-98. 10.1002/bies.201200053 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
36. Singh VK, Kalsan M, Kumar N, et al. Induced pluripotent branch cells: applications inside regenerative medicine, disease modeling, and medicine discovery. Front Cell Dev Biol 2015;3:2. 10.3389/fcell.2015.00002 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
37. Maury Y, Gauthier M, Peschanski M, et al. Human pluripotent branch cells intended disease modelling and medicine screening. Bioessays 2012;34:61-71. 10.1002/bies.201100071 [PubMed] [CrossRef] [Google Scholar]
38. Chopra A, Saluja M, Tillu G. Ayurveda-modern drug interface: A crucial appraisal on studies on Ayurvedic medicines to behave towards osteoarthritis and rheumatoid arthritis. J Ayurveda Integr Med 2010;1:190-8. 10.4103/0975-9476.72620 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
39. Kumar GP, Khanum F. Neuroprotective possible on phytochemicals. Pharmacogn Rev 2012;6:81-90. 10.4103/0973-7847.99898 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
40. Ray S, Ray A. Medhya Rasayanas inside Brain Function and Disease. Med chem 5:505-511. [Google Scholar]
41. Bizimenyera ES, Aderogba MA, Eloff JN, et al. Potential on neuroprotective antioxidant-based therapeutics from Peltophorum africanum Sond. (Fabaceae). Afr J Tradit Complement Altern Med 2006;4:99-106. [PMC for free article] [PubMed] [Google Scholar]
42. Joshi KS, Bhonde R. Insights from Ayurveda intended translational branch cell research. J Ayurveda Integr Med 2014;5:4-10. 10.4103/0975-9476.128846 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
43. Reena K, Abhimanyu K, Kumar KN. Formulation and standardization on Medhya Rasayana–A tale Ayurvedic mixture nootropic drug. Pharmacognosy Journal 2013;5:72-6. 10.1016/j.phcgj.2013.03.004 [CrossRef] [Google Scholar]
44. Dhingra D, Valecha R. Evaluation on the antidepressant-like action on Convolvulus pluricaulis choisy inside the mouse forced swim and tail suspension tests. Med Sci Monit 2007;13:BR155-61. [PubMed] [Google Scholar]
45. Stough C, Lloyd J, Clarke J, et al. The chronic effects on an extract on Bacopa monniera (Brahmi) on cognitive function inside well human subjects. Psychopharmacology (Berl) 2001;156:481-4. 10.1007/s002130100815 [PubMed] [CrossRef] [Google Scholar]
46. Holcomb LA, Dhanasekaran M, Hitt AR, et al. Bacopa monniera extract reduces amyloid levels inside PSAPP mice. J Alzheimers Dis 2006;9:243-51. [PubMed] [Google Scholar]
47. Saraf MK, Prabhakar S, Khanduja KL, et al. Bacopa monniera Attenuates Scopolamine-Induced Impairment on Spatial Memory inside Mice. Evid Based Complement Alternat Med 2011;2011:236186. 10.1093/ecam/neq038 [PMC for free article] [PubMed] [CrossRef] [Google Scholar]
48. Kuboyama T, Tohda C, Zhao J, et al. Axon- or dendrite-predominant product induced via constituents from Ashwagandha. Neuroreport 2002;13:1715-20. 10.1097/00001756-200210070-00005 [PubMed] [CrossRef] [Google Scholar]
49. Kumar V. Potential medicinal plants intended CNS disorders: an overview. Phytother Res 2006;20:1023-35. 10.1002/ptr.1970 [PubMed] [CrossRef] [Google Scholar]
oke explanation subject Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology hopefully writingthisadding insight thank you
Article this was posted onkategori , date06-09-2019
Post a Comment for "Novel Therapeutic Approaches: Rett Syndrome And Human Induced Pluripotent Stem Cell Technology Hemophilia Ayurvedic Herbal Treatment"